The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Acino Holding AG's share price is CHF113.60.
Acino Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2013 was CHF94.09. Hence, Acino Holding AG's PS Ratio for today is 1.21.
The historical rank and industry rank for Acino Holding AG's PS Ratio or its related term are showing as below:
XSWX:ACIN'
s PS Ratio Range Over the Past 10 Years
Min: 0.04 Med: 1.77 Max: 4.09
Current: 1.2
During the past 11 years, Acino Holding AG's highest PS Ratio was 4.09. The lowest was 0.04. And the median was 1.77.
XSWX:ACIN's PS Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.16
vs XSWX:ACIN: 1.20
Acino Holding AG revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Acino Holding AG was 3.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 22.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -16.40% per year.
During the past 11 years, Acino Holding AG's highest 3-Year average Revenue per Share Growth Rate was 22.50% per year. The lowest was -68.10% per year. And the median was -6.55% per year.
Back to Basics: PS Ratio
Acino Holding AG PS Ratio Historical Data
The historical data trend for Acino Holding AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acino Holding AG's PS Ratio
For the Drug Manufacturers - General subindustry, Acino Holding AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acino Holding AG's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Acino Holding AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Acino Holding AG's PS Ratio falls into.
Acino Holding AG PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Acino Holding AG's Share Price of today is CHF113.60.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Acino Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2013 was CHF94.09.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Acino Holding AG PS Ratio Related Terms
Thank you for viewing the detailed overview of Acino Holding AG's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:ACIN has been successfully added to your 